Researchers at the Okinawa Institute of Science and Technology (OIST) in Japan have developed a synthetic peptide, PHDP5, that successfully reversed Alzheimer’s symptoms in mice. The peptide targets and improves brain synaptic function, effectively restoring cognitive function and memory by reversing synapse damage. Treated mice exhibited the same cognitive function as healthy mice, highlighting the potential of PHDP5 to cross the blood-brain barrier and offer a new therapeutic approach for Alzheimer’s disease.
Alzheimer’s related synapse damage reversed by synthetic protein - Researchers at the Okinawa Institute of Science and Technology (OIST) have developed a potentially transformative approach to treating Alzheimer’s disease, A team from the former Cellular and Molecular Synaptic… https://t.co/gF8sV1yHP5
Alzheimer’s-related synapse damage reversed by synthetic protein A new therapy can reverse Alzheimer’s symptoms in mice, effectively treating cognitive decline and restoring memory. #biotech #alzheimers #alzheimerstreatment #study https://t.co/Y8CNb2ZU4L
🤩 Scientists Reverse Alzheimer's Synapse Damage In Mice. https://t.co/rjlNzD3vKr
SCIENTISTS REVERSE ALZHEIMER'S SYNAPSE DAMAGE IN MICE TREATED MICE WITH ALZHEIMER'S HAVE SAME COGNITIVE FUNCTION AS HEALTHY MICE. Scientists in Japan say they have reversed the signs of Alzheimer’s disease in lab mice by restoring the healthy function of synapses, critical… https://t.co/z8wqNCEFt4
Synthetic Peptide Reverses Alzheimer’s Symptoms Researchers developed a synthetic peptide, PHDP5, that successfully reversed Alzheimer’s symptoms in mice by targeting and improving brain synaptic function. The study highlights PHDP5’s ability to cross the blood-brain barrier… https://t.co/VF33pT1A67